Table 3.
Pathways/functions with altered protein abundance between AMR and AMS | Directionality | FSC232 vs. FSC201 | FSC016 vs. FSC013 |
---|---|---|---|
rpoB mutation (RifR) | rpsL mutation (StrR) | ||
General lipid metabolism | Up in AMR | 8* | 8 |
Fatty acid biosynthesis | Up in AMR | 8 | 6 |
Type 6 secretion system | Down in AMR | 14 | 15 |
TCA cycle | Up in AMR | 9 | 7 |
Purine biosynthesis | Up in AMR | 9 | 5 |
LPS biosynthesis | Up in AMR | 11 | 4 |
OMPs/OMP processing | Up in AMR | 4 | 6 |
tRNA ligase | Up in AMR | 8 | 6 |
Type 4 pili | Up in AMR | 1 | 4 |
Number of proteins in each pathway that were observed to be significantly differently expressed.